Publications by authors named "Steven Blum"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

21,864

Total Likes

185

Extended Reach

307,799

Social Features

44
T
Tumor location as a risk factor for severe immune-related adverse events.
Steven M Blum, Ben Ouyang, Leyre Zubiri, Daniel Leonard, Kamil Slowikowski

J Immunother Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semiautomated Production of Cell-Free Biosensors.
Dylan M Brown, Daniel A Phillips, David C Garcia, Anibal Arce, Tyler Lucci, Steven M Blum

ACS Synth Biol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial.
Thierry André, Elena Elez, Heinz-Josef Lenz, Lars Henrik Jensen, Yann Touchefeu, Steven I Blum

Lancet· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary of quality of life in CheckMate 9ER: Cabozantinib plus nivolumab in advanced renal cell carcinoma.
David Cella, Robert J Motzer, Cristina Suarez, Steven I Blum, Flavia Ejzykowicz

Future Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases.
Joseph J Zhao, Chin-Ann Johnny Ong, Supriya Srivastava, Daryl Kai Ann Chia, Haoran Ma, Steven M Blum

Gastroenterology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records.
Virginia H Sun, Julius C Heemelaar, Ibrahim Hadzic, Vineet K Raghu, Chia-Yun Wu, Steven M Blum

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses in checkpoint myocarditis across heart, blood and tumour.
Steven M Blum, Daniel A Zlotoff, Neal P Smith, Isabela J Kernin, Swetha Ramesh

Nature· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetric evaluation of adaptive planning for five-fraction gynecologic template-based interstitial brachytherapy.
Steven Blum, Jessica R Miller, Kristin A Bradley, Bethany Anderson, Hari Menon

Brachytherapy· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Relationship Between Health-Related Quality of Life and Overall Survival in Patients With Advanced Renal Cell Carcinoma in CheckMate 214.
David Cella, Toni K Choueiri, Melissa Hamilton, Steven I Blum, Cristina Ivanescu

Oncologist· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Nivolumab in Resectable Lung Cancer.
Tina Cascone, Mark M Awad, Jonathan D Spicer, Jie He, Shun Lu, Steven I Blum

N Engl J Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649.
Markus Moehler, Hong Xiao, Steven I Blum, Elena Elimova, David Cella

J Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor.
Steven M Blum, Daniel A Zlotoff, Neal P Smith, Isabela J Kernin, Swetha Ramesh

bioRxiv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer.
Sujin Hyung, Jihoon Ko, You Jeong Heo, Steven M Blum, Seung Tae Kim

Sci Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Bile Acids in Complex Matrices Using a Transcription Factor-Based Biosensor.
Kathryn Beabout, Amy M Ehrenworth Breedon, Steven M Blum, Aleksandr E Miklos, Matthew W Lux

ACS Biomater Sci Eng· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of immune-related adverse events (irAEs) and their treatment on antitumor immune responses.
Steven M Blum, Sherin J Rouhani, Ryan J Sullivan

Immunol Rev· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma.
Bradley McGregor, Daniel M Geynisman, Mauricio Burotto, Cristina Suárez, Maria T Bourlon, Steven I Blum

Eur Urol Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicities associated with immune checkpoint inhibitors: a systematic study.
Xiangyi Kong, Li Chen, Zhaohui Su, Ryan J Sullivan, Steven M Blum

Int J Surg· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
General population reference values for the Functional Assessment of Cancer Therapy-Lung and PROMIS-29.
Nisha A Mohindra, John Devin Peipert, Steven I Blum, James W Shaw, John R Penrod

Cancer Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes.
Martin Reck, Tudor-Eliade Ciuleanu, Manuel Cobo, Michael Schenker, Bogdan Zurawski, Steven I Blum

Eur J Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttreatment Exposure Rates for Y-Microsphere Patients: A Comparison of Products.
Steven Blum, Eugenio Silvestrini, Jonathan Weinstein, Craig Greben

J Nucl Med Technol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma.
Selina K Wong, Steven M Blum, Xiaopeng Sun, Inês P Da Silva, Leyre Zubiri

Eur J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing patient global impression of severity and patient global impression of change to evaluate test-retest reliability of depression, non-small cell lung cancer, and asthma measures.
Sonya Eremenco, Wen-Hung Chen, Steven I Blum, Elizabeth Nicole Bush, Donald M Bushnell

Qual Life Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.
Maria S Asdourian, Tracey S Otto, Ted V Jacoby, Nishi Shah, Leah L Thompson, Steven M Blum

J Am Acad Dermatol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-year follow-up and patient-reported outcomes from CheckMate 078: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer.
Jianhua Chang, Yi-Long Wu, Shun Lu, Jie Wang, Tony Mok, Steven I Blum

Lung Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis